Resources

by AstraZeneca

This resource provides information on IMFINZI and how it is used for treatment of several cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), removable stomach (gastric)

by LUNGevity Foundation

This program helps lung cancer patients manage their finances. It includes financial navigation and planning with personalized recommendations for resources that can reduce costs associated with treatment.

by CancerCare

This fact sheet provides an overview of lung cancer and explains how it is treated. It explains how to communicate with your healthcare team, how to stay informed about your cancer, and how to care for

by LUNGevity Foundation

This resource discusses accessing financial assistance for biomarker testing, including what to do if concerned about testing costs, if your health insurance denies coverage for testing, and how to access

by Patient Advocate Foundation (TotalAssist)

This resource provides financial assistance for out-of-pocket healthcare costs to NSCLC patients who meet the eligibility criteria, including costs related to medications, coinsurance, health insurance

by Boehringer Ingelheim

This program offers a range of services to help alleviate financial concerns around access. It includes resources and guidance to help patients understand treatment with GILOTRIF, which is used to treat

by Patient Advocate Foundation (TotalAssist)

This resource provides financial assistance for out-of-pocket healthcare costs to SCLC patients who meet the eligibility criteria, including costs related to medications, coinsurance, health insurance

by Patient Advocate Foundation (TotalAssist)

This resource provides support for patients with NSCLC who live in areas identified as having increased social and financial needs. It discusses eligibility requirements, which include household income,

by Bristol Myers Squibb

This resource helps cancer patients gain access and financial support to their prescribed BMS medications (e.g. ABRAXANE, IDHIFA, INREBIC, POMALYST, REVLIMID, THALOMID). It provides resources to help patients

by EMD Serono

This program offers patient support, reimbursement support, and co-pay assistance for BAVENCIO® and TEPMETKO®. BAVENCIO® (avelumab) is for patients with urothelial carcinoma (bladder cancer), kidney